Amund Gulsvik - Publications

Affiliations: 
Department of Clinical Medicine K2 University of Bergen, Bergen, Hordaland, Norway 

222 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Moll M, Sordillo JE, Ghosh AJ, Hayden LP, McDermott G, McGeachie MJ, Dahlin A, Tiwari A, Manmadkar MG, Abston ED, Pavuluri C, Saferali A, Begum S, Ziniti JP, Gulsvik A, et al. Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease. The Journal of Allergy and Clinical Immunology. PMID 37595761 DOI: 10.1016/j.jaci.2023.08.002  0.308
2023 Hayden LP, Hobbs BD, Busch R, Cho MH, Liu M, Lopes-Ramos CM, Lomas DA, Bakke P, Gulsvik A, Silverman EK, Crapo JD, Beaty TH, Laird NM, Lange C, DeMeo DL. X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study. Respiratory Research. 24: 38. PMID 36726148 DOI: 10.1186/s12931-023-02337-1  0.604
2022 Ratanachina J, Amaral AFS, De Matteis S, Lawin H, Mortimer K, Obaseki DO, Harrabi I, Denguezli M, Wouters EFM, Janson C, Nielsen R, Gulsvik A, Hacene Cherkaski H, Mejza F, Padukudru Anand M, et al. Association of respiratory symptoms and lung function with occupation in the multinational Burden of Obstructive Lung Disease (BOLD) study. The European Respiratory Journal. PMID 36028253 DOI: 10.1183/13993003.00469-2022  0.325
2022 Gereige JD, Xu H, Ortega VE, Cho MH, Liu M, Sakornsakolpat P, Silverman EK, Beaty TH, Miller BE, Bakke P, Gulsvik A, Hersh CP, Morrow JD, Ampleford EJ, Hawkins GA, et al. A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts. Erj Open Research. 8. PMID 35769418 DOI: 10.1183/23120541.00484-2021  0.58
2022 John C, Guyatt AL, Shrine N, Packer R, Olafsdottir TA, Liu J, Hayden LP, Chu SH, Koskela JT, Luan J, Li X, Terzikhan N, Xu H, Bartz TM, Petersen H, ... ... Gulsvik A, et al. Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap. Chest. PMID 35104449 DOI: 10.1016/j.chest.2021.12.674  0.657
2021 Stavem K, Johannessen A, Nielsen R, Gulsvik A. Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time. Plos One. 16: e0260416. PMID 34807953 DOI: 10.1371/journal.pone.0260416  0.319
2020 Gagnat AA, Gjerdevik M, Lie SA, Gulsvik A, Bakke P, Nielsen R. Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma. European Clinical Respiratory Journal. 7: 1799540. PMID 32944202 DOI: 10.1080/20018525.2020.1799540  0.691
2020 Gulsvik A, Bakke PS, Brøgger J, Nielsen R, Stavem K. Respiratory symptoms and mortality in four general population cohorts over 45 years. Respiratory Medicine. 170: 106060. PMID 32843179 DOI: 10.1016/J.Rmed.2020.106060  0.793
2020 Moll M, Sakornsakolpat P, Shrine N, Hobbs BD, DeMeo DL, John C, Guyatt AL, McGeachie MJ, Gharib SA, Obeidat M, Lahousse L, Wijnant SRA, Brusselle G, Meyers DA, Bleecker ER, ... ... Gulsvik A, et al. Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts. The Lancet. Respiratory Medicine. 8: 696-708. PMID 32649918 DOI: 10.1016/S2213-2600(20)30101-6  0.654
2020 Studnicka M, Horner A, Sator L, Buist AS, Lamprecht B, Zhong N, Liu S, Lu J, Ran P, Wang D, Zheng J, Zhou Y, Kocabaş A, Hancioglu A, Hanta I, ... ... Gulsvik A, et al. COPD: Should Diagnosis Match Physiology? Chest. 157: 473-475. PMID 32033652 DOI: 10.1016/J.Chest.2019.09.039  0.318
2020 Erdal M, Johannessen A, Bakke P, Gulsvik A, Eagan TM, Nielsen R. Incremental costs of COPD exacerbations in GOLD stage 2+ COPD in ever-smokers of a general population Respiratory Medicine: X. 2: 100014. DOI: 10.1016/j.yrmex.2020.100014  0.619
2019 Le LAK, Johannessen A, Hardie JA, Johansen OE, Gulsvik A, Vikse BE, Bakke P. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. International Journal of Chronic Obstructive Pulmonary Disease. 14: 1639-1655. PMID 31413559 DOI: 10.2147/Copd.S194019  0.643
2019 Shrine N, Guyatt AL, Erzurumluoglu AM, Jackson VE, Hobbs BD, Melbourne CA, Batini C, Fawcett KA, Song K, Sakornsakolpat P, Li X, Boxall R, Reeve NF, Obeidat M, Zhao JH, ... ... Gulsvik A, et al. Author Correction: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nature Genetics. PMID 31110354 DOI: 10.1038/S41588-019-0438-3  0.676
2019 Sakornsakolpat P, Prokopenko D, Lamontagne M, Reeve NF, Guyatt AL, Jackson VE, Shrine N, Qiao D, Bartz TM, Kim DK, Lee MK, Latourelle JC, Li X, Morrow JD, Obeidat M, ... ... Gulsvik A, et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nature Genetics. PMID 30804561 DOI: 10.1038/S41588-018-0342-2  0.705
2019 Shrine N, Guyatt AL, Erzurumluoglu AM, Jackson VE, Hobbs BD, Melbourne CA, Batini C, Fawcett KA, Song K, Sakornsakolpat P, Li X, Boxall R, Reeve NF, Obeidat M, Zhao JH, ... ... Gulsvik A, et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nature Genetics. PMID 30804560 DOI: 10.1038/S41588-018-0321-7  0.696
2019 Sakornsakolpat P, McCormack M, Bakke P, Gulsvik A, Make BJ, Crapo JD, Cho MH, Silverman EK. Genome-Wide Association Analysis of Single Breath Diffusing Capacity of Carbon Monoxide (DLCO). American Journal of Respiratory Cell and Molecular Biology. PMID 30694715 DOI: 10.1165/Rcmb.2018-0384Oc  0.664
2018 Gagnat AA, Gulsvik A, Bakke P, Gjerdevik M. Comparison of two lung cancer screening scores among patients with chronic obstructive pulmonary disease - a community study. The Clinical Respiratory Journal. PMID 30597746 DOI: 10.1111/Crj.12988  0.652
2018 Jouleh B, Erdal M, Eagan TM, Bakke P, Gulsvik A, Nielsen R. Guideline adherence in hospital recruited and population based COPD patients. Bmc Pulmonary Medicine. 18: 195. PMID 30572869 DOI: 10.1186/S12890-018-0756-8  0.642
2018 Lutz SM, Frederiksen B, Begum F, McDonald ML, Cho MH, Hobbs B, Parker MM, DeMeo DL, Hersh CP, Eringher M, Young K, Jiang L, Foreman MG, Kinney GL, Make BJ, ... ... Gulsvik A, et al. Common and rare variants genetic association analysis of cigarettes per day among ever smokers in COPD cases and controls. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 29767774 DOI: 10.1093/Ntr/Nty095  0.668
2018 Erdal M, Johannessen A, Eagan TM, Bakke P, Gulsvik A, Askildsen JE, Grønseth R. Costs of COPD exacerbations in a general population. European Respiratory Journal. 52. DOI: 10.1183/13993003.Congress-2018.Pa3157  0.641
2017 Aamli Gagnat A, Gjerdevik M, Gallefoss F, Coxson HO, Gulsvik A, Bakke P. Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort. The European Respiratory Journal. 49. PMID 28495686 DOI: 10.1183/13993003.01162-2016  0.652
2017 Radder JE, Gregory AD, Leme AS, Cho MH, Chu Y, Kelly NJ, Bakke P, Gulsvik A, Litonjua AA, Sparrow D, Beaty TH, Crapo JD, Silverman EK, Zhang Y, Berndt A, et al. Variable Susceptibility to Cigarette Smoke-Induced Emphysema in 34 Inbred Strains of Mice Implicates Abi3bp in Emphysema Susceptibility. American Journal of Respiratory Cell and Molecular Biology. PMID 28441029 DOI: 10.1165/Rcmb.2016-0220Oc  0.661
2017 Farahi N, Paige E, Balla J, Prudence E, Ferreira RC, Southwood M, Appleby SL, Bakke P, Gulsvik A, Litonjua AA, Sparrow D, Silverman EK, Cho MH, Danesh J, Paul DS, et al. Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma. Human Molecular Genetics. PMID 28334838 DOI: 10.1093/Hmg/Ddx053  0.694
2017 Busch R, Hobbs BD, Zhou J, Castaldi PJ, McGeachie MJ, Hardin ME, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Agusti A, Make BJ, Crapo JD, Calverley PM, ... ... Gulsvik A, et al. Genetic Association and Risk Scores in a COPD Meta-Analysis of 16,707 Subjects. American Journal of Respiratory Cell and Molecular Biology. PMID 28170284 DOI: 10.1165/Rcmb.2016-0331Oc  0.687
2017 Hobbs BD, de Jong K, Lamontagne M, Bossé Y, Shrine N, Artigas MS, Wain LV, Hall IP, Jackson VE, Wyss AB, London SJ, North KE, Franceschini N, Strachan DP, Beaty TH, ... ... Gulsvik A, et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nature Genetics. PMID 28166215 DOI: 10.1038/Ng.3752  0.712
2017 Wain LV, Shrine N, Artigas MS, Erzurumluoglu AM, Noyvert B, Bossini-Castillo L, Obeidat M, Henry AP, Portelli MA, Hall RJ, Billington CK, Rimington TL, Fenech AG, John C, Blake T, ... ... Gulsvik A, et al. Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nature Genetics. PMID 28166213 DOI: 10.1038/Ng.3787  0.687
2016 Hardin M, Cho MH, Sharma SS, Glass K, Castaldi PJ, McDonald ML, Aschard H, Senter-Sylvia J, Tantisira K, Weiss ST, Hersh CP, Morrow JD, Lomas D, Agusti A, Bakke P, ... Gulsvik A, et al. Sex-based Genetic Association Study Identifies CELSR1 as a Possible COPD Risk Locus Among Women. American Journal of Respiratory Cell and Molecular Biology. PMID 27854507 DOI: 10.1165/Rcmb.2016-0172Oc  0.659
2016 Boueiz A, Lutz SM, Cho MH, Hersh CP, Bowler RP, Washko GR, Halper-Stromberg E, Bakke P, Gulsvik A, Laird NM, Beaty TH, Coxson HO, Crapo JD, Silverman EK, Castaldi PJ, et al. Genome-Wide Association Study of the Genetic Determinants of Emphysema Distribution. American Journal of Respiratory and Critical Care Medicine. PMID 27669027 DOI: 10.1164/Rccm.201605-0997Oc  0.639
2016 Erdal M, Johannessen A, Eagan TM, Bakke P, Gulsvik A, Grønseth R. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. International Journal of Chronic Obstructive Pulmonary Disease. 11: 2099-108. PMID 27621614 DOI: 10.2147/Copd.S108720  0.656
2016 Storebø ML, Eagan TM, Eide GE, Gulsvik A, Thorsen E, Bakke PS. Change in pulmonary diffusion capacity in a general population sample over 9 years. European Clinical Respiratory Journal. 3: 31265. PMID 27600696 DOI: 10.3402/Ecrj.V3.31265  0.633
2016 Samulin Erdem J, Skaug V, Bakke P, Gulsvik A, Haugen A, Zienolddiny S. Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. Bmc Cancer. 16: 28. PMID 26780934 DOI: 10.1186/S12885-016-2061-3  0.619
2016 Skaug K, Eide GE, Gulsvik A. What is the minimum number of patients for quality control of lung cancer management in Norway? The Clinical Respiratory Journal. 10: 707-713. PMID 25620395 DOI: 10.1111/Crj.12274  0.769
2016 Erdal M, Johannessen A, Eagan T, Bakke P, Gulsvik A, Grønseth R. COPD exacerbations and predictors in a general population European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa1133  0.677
2015 Lutz SM, Cho MH, Young K, Hersh CP, Castaldi PJ, McDonald ML, Regan E, Mattheisen M, DeMeo DL, Parker M, Foreman M, Make BJ, Jensen RL, Casaburi R, Lomas DA, ... ... Gulsvik A, et al. A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. Bmc Genetics. 16: 138. PMID 26634245 DOI: 10.1186/S12863-015-0299-4  0.671
2015 Cho MH, Castaldi PJ, Hersh CP, Hobbs BD, Barr RG, Tal-Singer R, Bakke P, Gulsvik A, San José Estépar R, Van Beek EJ, Coxson HO, Lynch DA, Washko GR, Laird NM, Crapo JD, et al. A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. American Journal of Respiratory and Critical Care Medicine. 192: 559-69. PMID 26030696 DOI: 10.1164/Rccm.201501-0148Oc  0.674
2015 Dijkstra AE, Smolonska J, van den Berge M, Wijmenga C, Zanen P, Luinge MA, Platteel M, Lammers JW, Dahlback M, Tosh K, Hiemstra PS, Sterk PJ, Spira A, Vestbo J, Nordestgaard BG, ... ... Gulsvik A, et al. Correction: Susceptibility to Chronic Mucus Hypersecretion, a Genome Wide Association Study. Plos One. 10: e0129524. PMID 26024482 DOI: 10.1371/Journal.Pone.0129524  0.572
2015 Gjerdevik M, Grydeland TB, Washko GR, Coxson HO, Silverman EK, Gulsvik A, Bakke PS. The Relationship of Educational Attainment with Pulmonary Emphysema and Airway Wall Thickness. Annals of the American Thoracic Society. 12: 813-20. PMID 25822654 DOI: 10.1513/Annalsats.201410-485Oc  0.797
2015 Gulsvik AK, Henriksen AH, Svendsen E, Humerfelt S, Gulsvik A. Validity of the European short list of respiratory diseases: A 40-year autopsy study European Respiratory Journal. 45: 953-961. PMID 25359344 DOI: 10.1183/09031936.00085214  0.675
2015 Castaldi PJ, Cho MH, Zhou X, Qiu W, Mcgeachie M, Celli B, Bakke P, Gulsvik A, Lomas DA, Crapo JD, Beaty TH, Rennard S, Harshfield B, Lange C, Singh D, et al. Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci. Human Molecular Genetics. 24: 1200-10. PMID 25315895 DOI: 10.1093/Hmg/Ddu525  0.66
2015 Dijkstra AE, Boezen HM, van den Berge M, Vonk JM, Hiemstra PS, Barr RG, Burkart KM, Manichaikul A, Pottinger TD, Silverman EK, Cho MH, Crapo JD, Beaty TH, Bakke P, Gulsvik A, et al. Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. The European Respiratory Journal. 45: 60-75. PMID 25234806 DOI: 10.1183/09031936.00093314  0.686
2015 Jouleh B, Gulsvik A, Eagan T, Grønseth R. COPD guideline adherence in hospital- and population-recruited COPD patients European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa4053  0.328
2015 Samulin-Erdem J, Skaug V, Bakke P, Gulsvik A, Haugen A, Zienolddiny S. Abstract 1214: TP53 affects SOX2 copy number alterations and expression in non-small cell lung cancer Cancer Research. 75: 1214-1214. DOI: 10.1158/1538-7445.Am2015-1214  0.621
2014 Erdal M, Johannessen A, Askildsen JE, Eagan T, Gulsvik A, Grønseth R. Productivity losses in chronic obstructive pulmonary disease: a population-based survey. Bmj Open Respiratory Research. 1: e000049. PMID 25553244 DOI: 10.1136/Bmjresp-2014-000049  0.394
2014 Lee JH, Cho MH, Hersh CP, McDonald ML, Crapo JD, Bakke PS, Gulsvik A, Comellas AP, Wendt CH, Lomas DA, Kim V, Silverman EK. Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. Respiratory Research. 15: 113. PMID 25241909 DOI: 10.1186/S12931-014-0113-2  0.679
2014 McDonald ML, Mattheisen M, Cho MH, Liu YY, Harshfield B, Hersh CP, Bakke P, Gulsvik A, Lange C, Beaty TH, Silverman EK. Beyond GWAS in COPD: probing the landscape between gene-set associations, genome-wide associations and protein-protein interaction networks. Human Heredity. 78: 131-9. PMID 25171373 DOI: 10.1159/000365589  0.64
2014 McDonald ML, Cho MH, Sørheim IC, Lutz SM, Castaldi PJ, Lomas DA, Coxson HO, Edwards LD, MacNee W, Vestbo J, Yates JC, Agusti A, Calverley PM, Celli B, Crim C, ... ... Gulsvik A, et al. Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology. 51: 678-87. PMID 24825563 DOI: 10.1165/Rcmb.2014-0135Oc  0.673
2014 Dijkstra AE, Smolonska J, van den Berge M, Wijmenga C, Zanen P, Luinge MA, Platteel M, Lammers JW, Dahlback M, Tosh K, Hiemstra PS, Sterk PJ, Spira A, Vestbo J, Nordestgaard BG, ... ... Gulsvik A, et al. Susceptibility to chronic mucus hypersecretion, a genome wide association study. Plos One. 9: e91621. PMID 24714607 DOI: 10.1371/Journal.Pone.0091621  0.674
2014 Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, Demeo DL, Sylvia JS, Ziniti J, Laird NM, Lange C, Litonjua AA, Sparrow D, Casaburi R, Barr RG, ... ... Gulsvik A, et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. The Lancet. Respiratory Medicine. 2: 214-25. PMID 24621683 DOI: 10.1016/S2213-2600(14)70002-5  0.671
2014 Qiao D, Cho MH, Fier H, Bakke PS, Gulsvik A, Silverman EK, Lange C. On the simultaneous association analysis of large genomic regions: a massive multi-locus association test. Bioinformatics (Oxford, England). 30: 157-64. PMID 24262215 DOI: 10.1093/Bioinformatics/Btt654  0.602
2014 Grønseth R, Vollmer WM, Hardie JA, Ólafsdóttir IS, Lamprecht B, Buist AS, Gnatiuc L, Gulsvik A, Johannessen A, Enright P. Predictors of dyspnoea prevalence: results from the BOLD study. The European Respiratory Journal. 43: 1610-20. PMID 24176991 DOI: 10.1183/09031936.00036813  0.408
2014 Burkett KM, McNeney B, Graham J, Greenwood CMT, Drichel D, Herold C, Lacour A, Ramirez A, Jessen F, Maier W, Noethen MM, Leber M, Vaitsiakhovich T, Becker T, McDonald MN, ... ... Gulsvik A, et al. Contents Vol. 78, 2014 Human Heredity. 78. DOI: 10.1159/000369520  0.558
2013 Aminuddin F, Hackett TL, Stefanowicz D, Saferali A, Paré PD, Gulsvik A, Bakke P, Cho MH, Litonjua A, Lomas DA, Anderson WH, Beaty TH, Silverman EK, Sandford AJ. Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. Bmc Pulmonary Medicine. 13: 64. PMID 24192154 DOI: 10.1186/1471-2466-13-64  0.676
2013 Waatevik M, Skorge TD, Omenaas E, Bakke PS, Gulsvik A, Johannessen A. Increased prevalence of chronic obstructive pulmonary disease in a general population. Respiratory Medicine. 107: 1037-45. PMID 23680166 DOI: 10.1016/J.Rmed.2013.04.008  0.773
2013 Johannessen A, Nilsen RM, Storebø M, Gulsvik A, Eagan T, Bakke P. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. American Journal of Respiratory and Critical Care Medicine. 188: 51-9. PMID 23590268 DOI: 10.1164/Rccm.201212-2276Oc  0.68
2013 Zhou X, Qiu W, Sathirapongsasuti JF, Cho MH, Mancini JD, Lao T, Thibault DM, Litonjua AA, Bakke PS, Gulsvik A, Lomas DA, Beaty TH, Hersh CP, Anderson C, Geigenmuller U, et al. Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. Genomics. 101: 263-72. PMID 23459001 DOI: 10.1016/J.Ygeno.2013.02.010  0.631
2013 Johannessen A, Skorge TD, Bottai M, Grydeland TB, Nilsen RM, Coxson H, Dirksen A, Omenaas E, Gulsvik A, Bakke P. Mortality by level of emphysema and airway wall thickness. American Journal of Respiratory and Critical Care Medicine. 187: 602-8. PMID 23328525 DOI: 10.1164/Rccm.201209-1722Oc  0.771
2013 Siedlinski M, Tingley D, Lipman PJ, Cho MH, Litonjua AA, Sparrow D, Bakke P, Gulsvik A, Lomas DA, Anderson W, Kong X, Rennard SI, Beaty TH, Hokanson JE, Crapo JD, et al. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Human Genetics. 132: 431-41. PMID 23299987 DOI: 10.1007/S00439-012-1262-3  0.681
2013 Tekpli X, Landvik NE, Skaug V, Gulsvik A, Haugen A, Zienolddiny S. Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations. International Journal of Cancer. 132: 1811-20. PMID 23011884 DOI: 10.1002/Ijc.27870  0.325
2013 Accordini S, Corsico AG, Braggion M, Gerbase MW, Gislason D, Gulsvik A, Heinrich J, Janson C, Jarvis D, Jõgi R, Pin I, Schoefer Y, Bugiani M, Cazzoletti L, Cerveri I, et al. The cost of persistent asthma in Europe: an international population-based study in adults. International Archives of Allergy and Immunology. 160: 93-101. PMID 22948386 DOI: 10.1159/000338998  0.325
2012 Kato B, Gulsvik A, Vollmer W, Janson C, Studnika M, Buist S, Burney P. Can spirometric norms be set using pre- or post- bronchodilator test results in older people? Respiratory Research. 13: 102. PMID 23157675 DOI: 10.1186/1465-9921-13-102  0.382
2012 Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong X, Bakke P, Gulsvik A, Agustí A, Wouters E, Celli B, Coxson H, Vestbo J, MacNee W, Yates JC, et al. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 186: 1238-47. PMID 23144326 DOI: 10.1164/Rccm.201206-1013Oc  0.677
2012 Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, Lopez LM, Smith AV, Heckbert SR, Smolonska J, Tang W, Loth DW, Curjuric I, Hui J, Cho MH, Latourelle JC, ... ... Gulsvik A, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. American Journal of Respiratory and Critical Care Medicine. 186: 622-32. PMID 22837378 DOI: 10.1164/Rccm.201202-0366Oc  0.7
2012 Gulsvik AK, Gulsvik A, Skovlund E, Thelle DS, Mowé M, Humerfelt S, Wyller TB. The association between lung function and fatal stroke in a community followed for 4 decades. Journal of Epidemiology and Community Health. 66: 1030-6. PMID 22493479 DOI: 10.1136/Jech-2011-200312  0.659
2012 Aminuddin F, Akhabir L, Stefanowicz D, Paré PD, Connett JE, Anthonisen NR, Fahy JV, Seibold MA, Burchard EG, Eng C, Gulsvik A, Bakke P, Cho MH, Litonjua A, Lomas DA, et al. Genetic association between human chitinases and lung function in COPD Human Genetics. 131: 1105-1114. PMID 22200767 DOI: 10.1007/S00439-011-1127-1  0.688
2012 Cho MH, Castaldi PJ, Wan ES, Siedlinski M, Hersh CP, Demeo DL, Himes BE, Sylvia JS, Klanderman BJ, Ziniti JP, Lange C, Litonjua AA, Sparrow D, Regan EA, Make BJ, ... ... Gulsvik A, et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Human Molecular Genetics. 21: 947-57. PMID 22080838 DOI: 10.1093/Hmg/Ddr524  0.666
2012 Rutten EPA, Bakke PS, Pillai SG, Wagers S, Grydeland TB, Gulsvik A, Wouters EFM. The association between body composition and self-reported co-morbidity in subjects with chronic obstructive pulmonary disease Open Journal of Internal Medicine. 2: 100-106. DOI: 10.4236/Ojim.2012.22019  0.791
2011 Qiu W, Cho MH, Riley JH, Anderson WH, Singh D, Bakke P, Gulsvik A, Litonjua AA, Lomas DA, Crapo JD, Beaty TH, Celli BR, Rennard S, Tal-Singer R, Fox SM, et al. Genetics of sputum gene expression in chronic obstructive pulmonary disease. Plos One. 6: e24395. PMID 21949713 DOI: 10.1371/Journal.Pone.0024395  0.662
2011 Brehm JM, Hagiwara K, Tesfaigzi Y, Bruse S, Mariani TJ, Bhattacharya S, Boutaoui N, Ziniti JP, Soto-Quiros ME, Avila L, Cho MH, Himes B, Litonjua AA, Jacobson F, Bakke P, ... Gulsvik A, et al. Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax. 66: 1085-90. PMID 21921092 DOI: 10.1136/Thoraxjnl-2011-200017  0.681
2011 Siedlinski M, Cho MH, Bakke P, Gulsvik A, Lomas DA, Anderson W, Kong X, Rennard SI, Beaty TH, Hokanson JE, Crapo JD, Silverman EK, Coxson H, Edwards L, Knobil K, et al. Genome-wide association study of smoking behaviours in patients with COPD Thorax. 66: 894-902. PMID 21685187 DOI: 10.1136/Thoraxjnl-2011-200154  0.658
2011 Castaldi PJ, Cho MH, Litonjua AA, Bakke P, Gulsvik A, Lomas DA, Anderson W, Beaty TH, Hokanson JE, Crapo JD, Laird N, Silverman EK. The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility American Journal of Respiratory Cell and Molecular Biology. 45: 1147-1153. PMID 21659657 DOI: 10.1165/Rcmb.2011-0055Oc  0.666
2011 Rutten EP, Grydeland TB, Pillai SG, Wagers S, Dirksen A, Coxson HO, Gulsvik A, Wouters EF, Bakke PS. Quantitative CT: Associations between Emphysema, Airway Wall Thickness and Body Composition in COPD. Pulmonary Medicine. 2011: 419328. PMID 21647214 DOI: 10.1155/2011/419328  0.802
2011 Lipman PJ, Cho MH, Bakke P, Gulsvik A, Kong X, Lomas DA, Anderson W, Silverman EK, Lange C. On the follow-up of genome-wide association studies: an overall test for the most promising SNPs. Genetic Epidemiology. 35: 303-9. PMID 21374717 DOI: 10.1002/Gepi.20578  0.628
2011 Castaldi PJ, Demeo DL, Hersh CP, Lomas DA, Soerheim IC, Gulsvik A, Bakke P, Rennard S, Pare P, Vestbo J, Silverman EK. Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax. 66: 903-9. PMID 21163806 DOI: 10.1136/Thx.2010.146118  0.678
2011 Skaug K, Eide GE, Gulsvik A. Predictors of long-term survival of lung cancer patients in a Norwegian community. The Clinical Respiratory Journal. 5: 50-8. PMID 21159141 DOI: 10.1111/J.1752-699X.2010.00200.X  0.772
2011 Grydeland TB, Thorsen E, Dirksen A, Jensen R, Coxson HO, Pillai SG, Sharma S, Eide GE, Gulsvik A, Bakke PS. Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respiratory Medicine. 105: 343-51. PMID 21074394 DOI: 10.1016/J.Rmed.2010.10.018  0.773
2011 Wan ES, Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Won S, Lange C, Pillai SG, Anderson WH, Kong X, Lomas DA, Bakke PS, Gulsvik A, Regan EA, et al. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology. 45: 304-10. PMID 21037115 DOI: 10.1165/Rcmb.2010-0294Oc  0.695
2011 Nielsen R, Johannessen A, Omenaas ER, Bakke PS, Askildsen JE, Gulsvik A. Excessive costs of COPD in ever-smokers. A longitudinal community study. Respiratory Medicine. 105: 485-93. PMID 21030232 DOI: 10.1016/J.Rmed.2010.08.009  0.751
2011 Kong X, Cho MH, Anderson W, Coxson HO, Muller N, Washko G, Hoffman EA, Bakke P, Gulsvik A, Lomas DA, Silverman EK, Pillai SG. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. American Journal of Respiratory and Critical Care Medicine. 183: 43-9. PMID 20709820 DOI: 10.1164/Rccm.201004-0541Oc  0.678
2011 Bakke PS, Zhu G, Gulsvik A, Kong X, Agusti AG, Calverley PM, Donner CF, Levy RD, Make BJ, Paré PD, Rennard SI, Vestbo J, Wouters EF, Anderson W, Lomas DA, et al. Candidate genes for COPD in two large data sets. The European Respiratory Journal. 37: 255-63. PMID 20562129 DOI: 10.1183/09031936.00091709  0.672
2011 Foreman MG, Kong X, DeMeo DL, Pillai SG, Hersh CP, Bakke P, Gulsvik A, Lomas DA, Litonjua AA, Shapiro SD, Tal-Singer R, Silverman EK. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology. 44: 316-22. PMID 20448057 DOI: 10.1165/Rcmb.2009-0360Oc  0.653
2011 Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Author's response Thorax. 66: 922. DOI: 10.1136/thx.2010.153478  0.52
2010 Sørheim IC, Bakke P, Gulsvik A, Pillai SG, Johannessen A, Gaarder PI, Campbell EJ, Agustí A, Calverley PM, Donner CF, Make BJ, Rennard SI, Vestbo J, Wouters EF, Paré PD, et al. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest. 138: 1125-32. PMID 20595457 DOI: 10.1378/Chest.10-0746  0.642
2010 Sørheim IC, Johannessen A, Grydeland TB, Omenaas ER, Gulsvik A, Bakke PS. Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? The Clinical Respiratory Journal. 4: 89-96. PMID 20565482 DOI: 10.1111/J.1752-699X.2009.00154.X  0.779
2010 Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 65: 480-5. PMID 20522842 DOI: 10.1136/Thx.2009.122002  0.672
2010 Hersh CP, Pillai SG, Zhu G, Lomas DA, Bakke P, Gulsvik A, DeMeo DL, Klanderman BJ, Lazarus R, Litonjua AA, Sparrow D, Reilly JJ, Agusti A, Calverley PM, Donner CF, et al. Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. American Journal of Respiratory and Critical Care Medicine. 182: 605-13. PMID 20463177 DOI: 10.1164/Rccm.200910-1586Oc  0.639
2010 Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber G, Vollenweider P, Preisig M, Wareham NJ, Zhao JH, Loos RJ, ... ... Gulsvik A, et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics. 42: 436-40. PMID 20418889 DOI: 10.1038/Ng.572  0.642
2010 Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. The Clinical Respiratory Journal. 4: 13-21. PMID 20298413 DOI: 10.1111/J.1752-699X.2009.00137.X  0.414
2010 Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, Lange C, Won S, Murphy JR, Beaty TH, Regan EA, ... ... Gulsvik A, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nature Genetics. 42: 200-2. PMID 20173748 DOI: 10.1038/Ng.535  0.689
2010 Johannessen A, Eagan TM, Omenaas ER, Bakke PS, Gulsvik A. Socioeconomic risk factors for lung function decline in a general population. The European Respiratory Journal. 36: 480-7. PMID 20150201 DOI: 10.1183/09031936.00186509  0.751
2010 Grydeland TB, Dirksen A, Coxson HO, Eagan TM, Thorsen E, Pillai SG, Sharma S, Eide GE, Gulsvik A, Bakke PS. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. American Journal of Respiratory and Critical Care Medicine. 181: 353-9. PMID 19926869 DOI: 10.1164/Rccm.200907-1008Oc  0.785
2010 Cazzoletti L, Marcon A, Corsico A, Janson C, Jarvis D, Pin I, Accordini S, Bugiani M, Cerveri I, Gislason D, Gulsvik A, de Marco R. Asthma severity according to Global Initiative for Asthma and its determinants: an international study. International Archives of Allergy and Immunology. 151: 70-9. PMID 19672098 DOI: 10.1159/000232572  0.331
2009 Nielsen R, Johannessen A, Bakke PS, Askildsen JE, Omenaas ER, Gulsvik A. Aspects of healthcare utilisation in self-reported obstructive lung disease. The Clinical Respiratory Journal. 3: 34-41. PMID 20298370 DOI: 10.1111/J.1752-699X.2008.00106.X  0.783
2009 Sørheim IC, Gulsvik A, Bakke PS, Brøgger JC, Grydeland TB, Silverman EK. [Genetics in chronic obstructive pulmonary disease]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 129: 2104-7. PMID 19855448 DOI: 10.4045/Tidsskr.09.0713  0.795
2009 Tollefsen E, Gulsvik A, Bakke P, Fondenes O. [Prevalence of home ventilation therapy in Norway]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 129: 2094-7. PMID 19855446 DOI: 10.4045/Tidsskr.08.0716  0.603
2009 Skorge TD, Eagan TM, Eide GE, Gulsvik A, Bakke PS. Occupational exposure and incidence of respiratory disorders in a general population. Scandinavian Journal of Work, Environment & Health. 35: 454-61. PMID 19806271 DOI: 10.5271/Sjweh.1352  0.641
2009 Skaug K, Eide GE, Gulsvik A. Hospitalisation days in patients with lung cancer in a general population. Respiratory Medicine. 103: 1941-8. PMID 19539455 DOI: 10.1016/J.Rmed.2009.05.016  0.774
2009 Vollmer WM, Gíslason T, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. European Respiratory Journal. 34: 588-597. PMID 19460786 DOI: 10.1183/09031936.00164608  0.445
2009 Zhu G, Agusti A, Gulsvik A, Bakke P, Coxson H, Lomas DA, Silverman EK, Pillai SG. CTLA4 gene polymorphisms are associated with chronic bronchitis. The European Respiratory Journal. 34: 598-604. PMID 19386687 DOI: 10.1183/09031936.00141808  0.668
2009 Nielsen R, Johannessen A, Benediktsdottir B, Gislason T, Buist AS, Gulsvik A, Sullivan SD, Lee TA. Present and future costs of COPD in Iceland and Norway: results from the BOLD study. The European Respiratory Journal. 34: 850-7. PMID 19357148 DOI: 10.1183/09031936.00166108  0.36
2009 Grydeland TB, Dirksen A, Coxson HO, Pillai SG, Sharma S, Eide GE, Gulsvik A, Bakke PS. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking European Respiratory Journal. 34: 858-865. PMID 19324952 DOI: 10.1183/09031936.00167908  0.813
2009 Marcon A, Corsico A, Cazzoletti L, Bugiani M, Accordini S, Almar E, Cerveri I, Gislason D, Gulsvik A, Janson C, Jarvis D, Martínez-Moratalla J, Pin I, de Marco R. Body mass index, weight gain, and other determinants of lung function decline in adult asthma. The Journal of Allergy and Clinical Immunology. 123: 1069-74, 1074.e1-4. PMID 19321196 DOI: 10.1016/J.Jaci.2009.01.040  0.368
2009 Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, Ruppert A, Lødrup Carlsen KC, Roses A, Anderson W, Rennard SI, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. Plos Genetics. 5: e1000421. PMID 19300482 DOI: 10.1371/Journal.Pgen.1000421  0.693
2009 Zhu G, Gulsvik A, Bakke P, Ghatta S, Anderson W, Lomas DA, Silverman EK, Pillai SG. Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Human Molecular Genetics. 18: 2053-62. PMID 19279160 DOI: 10.1093/Hmg/Ddp111  0.671
2009 Haegstad LK, Bjotveit T, Johannessen A, Gulsvik A. How frequently are physiological variables recorded in the emergency room in patients with obstructive pulmonary diseases and pneumonia? Primary Care Respiratory Journal : Journal of the General Practice Airways Group. 18: 95-9. PMID 18830520 DOI: 10.3132/Pcrj.2008.00057  0.368
2009 Nielsen R, Johannessen A, Bakke P, Askildsen J, Omenaas E, Gulsvik A. How expensive is comorbidity in COPD? Respiratory Medicine. 103: S7. DOI: 10.1016/S0954-6111(09)70018-6  0.764
2008 Sørheim I-, Gulsvik A. Genetics of chronic obstructive pulmonary disease: a case–control study in Bergen, Norway Clinical Respiratory Journal. 2: 129-131. PMID 20298363 DOI: 10.1111/J.1752-699X.2008.00097.X  0.419
2008 Nielsen R, Klemmetsby M, Gulsvik A. Economics of COPD: literature review and experiences from field work. Clinical Respiratory Journal. 2: 104-110. PMID 20298358 DOI: 10.1111/J.1752-699X.2008.00092.X  0.374
2008 Omenaas E, Svanes C, Janson C, Toren K, Jogi R, Gislason T, Franklin KA, Gulsvik A. What can we learn about asthma and allergy from the follow-up of the RHINE and the ECRHS studies? The Clinical Respiratory Journal. 2: 45-52. PMID 20298349 DOI: 10.1111/J.1752-699X.2008.00083.X  0.628
2008 Gulsvik A, Humerfelt S, Bakke PS, Omenaas ER, Lehmann S. Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. The Clinical Respiratory Journal. 2: 10-25. PMID 20298346 DOI: 10.1111/J.1752-699X.2008.00080.X  0.809
2008 Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Asthma and health-related quality of life - effect of adjusting for potential confounders. The Clinical Respiratory Journal. 2: 106-15. PMID 20298315 DOI: 10.1111/J.1752-699X.2008.00047.X  0.624
2008 Franklin KA, Janson C, Gíslason T, Gulsvik A, Gunnbjörnsdottir M, Laerum BN, Lindberg E, Norrman E, Nyström L, Omenaas E, Torén K, Svanes C. Early life environment and snoring in adulthood. Respiratory Research. 9: 63. PMID 18721453 DOI: 10.1186/1465-9921-9-63  0.572
2008 Nielsen R, Johannessen A, Schnelle HM, Bakke PS, Askildsen JE, Omenaas ER, Gulsvik A. Repeatability of health economic data in COPD. Respiratory Medicine. 102: 1556-62. PMID 18674894 DOI: 10.1016/J.Rmed.2008.06.008  0.713
2008 Siroux V, Boudier A, Anto JM, Cazzoletti L, Accordini S, Alonso J, Cerveri I, Corsico A, Gulsvik A, Jarvis D, de Marco R, Marcon A, Marques EA, Bugiani M, Janson C, et al. Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy. 63: 547-54. PMID 18394129 DOI: 10.1111/J.1398-9995.2008.01638.X  0.354
2008 Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine. 102: 399-406. PMID 18061422 DOI: 10.1016/J.Rmed.2007.10.012  0.647
2008 Frostad A, Søyseth V, Haldorsen T, Andersen A, Gulsvik A. Impact of respiratory symptoms on lung cancer: 30-year follow-up of an urban population. Lung Cancer (Amsterdam, Netherlands). 60: 22-30. PMID 17959269 DOI: 10.1016/J.Lungcan.2007.09.002  0.805
2007 Gulsvik A, Myrseth SE, Henrichsen SH, Humerfelt S, Omenaas E. Increased awareness of COPD in the Norwegian population. The Clinical Respiratory Journal. 1: 118-9. PMID 20298291 DOI: 10.1111/J.1752-699X.2007.00026.X  0.765
2007 Accordini S, Corsico A, Cerveri I, Gislason D, Gulsvik A, Janson C, Jarvis D, Marcon A, Pin I, Vermeire P, Almar E, Bugiani M, Cazzoletti L, Duran-Tauleria E, Jõgi R, et al. The socio-economic burden of asthma is substantial in Europe. Allergy. 63: 116-124. PMID 18053021 DOI: 10.1111/J.1398-9995.2007.01523.X  0.375
2007 Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jõgi R, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. The Journal of Allergy and Clinical Immunology. 120: 1360-7. PMID 17981317 DOI: 10.1016/J.Jaci.2007.09.019  0.327
2007 Laerum BN, Wentzel-Larsen T, Gulsvik A, Omenaas E, Gíslason T, Janson C, Svanes C. Relationship of fish and cod oil intake with adult asthma. Clinical & Experimental Allergy. 37: 1616-1623. PMID 17877766 DOI: 10.1111/J.1365-2222.2007.02821.X  0.637
2007 Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (London, England). 370: 741-50. PMID 17765523 DOI: 10.1016/S0140-6736(07)61377-4  0.421
2007 Frostad A, Soyseth V, Haldorsen T, Andersen A, Gulsvik A. Respiratory symptoms and long-term cardiovascular mortality. Respiratory Medicine. 101: 2289-96. PMID 17681463 DOI: 10.1016/J.Rmed.2007.06.023  0.788
2007 Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Changes in respiratory symptoms and health-related quality of life. Chest. 131: 1890-7. PMID 17505046 DOI: 10.1378/Chest.06-2629  0.625
2007 Zhu G, Warren L, Aponte J, Gulsvik A, Bakke P, Anderson WH, Lomas DA, Silverman EK, Pillai SG. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. American Journal of Respiratory and Critical Care Medicine. 176: 167-73. PMID 17446335 DOI: 10.1164/Rccm.200611-1723Oc  0.659
2007 Johannessen A, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Feasible and simple exclusion criteria for pulmonary reference populations. Thorax. 62: 792-8. PMID 17389756 DOI: 10.1136/Thx.2006.071480  0.776
2007 Laerum BN, Svanes C, Wentzel-Larsen T, Gulsvik A, Torén K, Norrman E, Gíslason T, Janson C, Omenaas E. Young maternal age at delivery is associated with asthma in adult offspring. Respiratory Medicine. 101: 1431-8. PMID 17350816 DOI: 10.1016/J.Rmed.2007.01.020  0.622
2007 Bisgaard H, Pedersen S, Anhøj J, Agertoft L, Hedlin G, Gulsvik A, Bjermer L, Carlsen KH, Nordvall L, Lundbäck B, Wennergren G, Werner S, Bønnelykke K, Weiss ST. Determinants of lung function and airway hyperresponsiveness in asthmatic children Respiratory Medicine. 101: 1477-1482. PMID 17336509 DOI: 10.1016/J.Rmed.2007.01.013  0.334
2007 Skaug K, Eide GE, Gulsvik A. Prevalence and predictors of symptoms in the terminal stage of lung cancer: A community study. Chest. 131: 389-94. PMID 17296638 DOI: 10.1378/Chest.06-1233  0.777
2007 de Marco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, Cerveri I, Corsico A, Gislason D, Gulsvik A, Jõgi R, Martínez-Moratalla J, Pin I, Janson C. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. The Journal of Allergy and Clinical Immunology. 119: 611-7. PMID 17258304 DOI: 10.1016/J.Jaci.2006.11.696  0.39
2007 Corsico AG, Cazzoletti L, de Marco R, Janson C, Jarvis D, Zoia MC, Bugiani M, Accordini S, Villani S, Marinoni A, Gislason D, Gulsvik A, Pin I, Vermeire P, Cerveri I. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respiratory Medicine. 101: 1363-7. PMID 17188854 DOI: 10.1016/J.Rmed.2006.11.012  0.318
2007 Lehmann S, Bakke PS, Eide GE, Gulsvik A. Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community. Respiratory Medicine. 101: 1183-90. PMID 17188486 DOI: 10.1016/J.Rmed.2006.11.007  0.622
2007 Skorge TD, Eagan TM, Eide GE, Gulsvik A, Bakke PS. Exposure to environmental tobacco smoke in a general population. Respiratory Medicine. 101: 277-85. PMID 16814538 DOI: 10.1016/J.Rmed.2006.05.010  0.627
2006 Frostad A, Soyseth V, Haldorsen T, Andersen A, Gulsvik A. Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia Thorax. 61: 951-956. PMID 16809414 DOI: 10.1136/Thx.2006.059436  0.809
2006 de Marco R, Marcon A, Jarvis D, Accordini S, Almar E, Bugiani M, Carolei A, Cazzoletti L, Corsico A, Gislason D, Gulsvik A, Jõgi R, Marinoni A, Martínez-Moratalla J, Pin I, et al. Prognostic factors of asthma severity: a 9-year international prospective cohort study. The Journal of Allergy and Clinical Immunology. 117: 1249-56. PMID 16750983 DOI: 10.1016/J.Jaci.2006.03.019  0.331
2006 Frostad A, Søyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. Journal of Internal Medicine. 259: 520-529. PMID 16629856 DOI: 10.1111/J.1365-2796.2006.01631.X  0.797
2006 Brøgger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. The European Respiratory Journal. 27: 682-8. PMID 16585076 DOI: 10.1183/09031936.06.00057005  0.809
2006 Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implications for disease management. American Journal of Respiratory and Critical Care Medicine. 173: 1316-25. PMID 16556696 DOI: 10.1164/Rccm.200601-023Oc  0.754
2006 Gómez Real F, Svanes C, Björnsson EH, Franklin KA, Franklin K, Gislason D, Gislason T, Gulsvik A, Janson C, Jögi R, Kiserud T, Norbäck D, Nyström L, Torén K, Wentzel-Larsen T, et al. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey. Thorax. 61: 34-40. PMID 16244093 DOI: 10.1136/Thx.2005.040881  0.594
2006 Lehmann S, Bakke PS, Eide GE, Humerfelt S, Gulsvik A. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist. Pulmonary Pharmacology & Therapeutics. 19: 272-80. PMID 16169762 DOI: 10.1016/J.Pupt.2005.07.006  0.78
2006 Gulsvik A, Gallefoss F, Dirksen A, Kinnula V, Gislason T, Janson C. A critical evaluation of the guidelines of obstructive lung disease and their implementation Respiratory Medicine. 100. DOI: 10.1016/J.Rmed.2006.03.024  0.344
2006 Gulsvik A, Boman G, Dahl R, Gislason T, Nieminen M. The burden of obstructive lung disease in the Nordic countries Respiratory Medicine. 100. DOI: 10.1016/J.Rmed.2006.03.021  0.405
2006 Gulsvik A, Omenaas ER. Heath care, management and guidelines of obstructive lung disease in the Nordic countries Respiratory Medicine. 100. DOI: 10.1016/J.Rmed.2006.03.020  0.307
2005 Janson C, Marco Rd, Accordini S, Almar E, Bugiani M, Carolei A, Cazzoletti L, Cerveri I, Corsico A, Duran-Tauleria E, Gislason D, Gulsvik A, Jögi R, Marinoni A, Martínez-Moratalla J, et al. Changes in the use of anti-asthmatic medication in an international cohort. European Respiratory Journal. 26: 1047-1055. PMID 16319334 DOI: 10.1183/09031936.05.00031905  0.345
2005 Laerum BN, Svanes C, Wentzel-Larsen T, Gulsvik A, Iversen M, Gislason T, Jögi R, Norrman E, Janson C, Omenaas E. The association between birth size and atopy in young North‐European adults Clinical & Experimental Allergy. 35: 1022-1027. PMID 16120083 DOI: 10.1111/J.1365-2222.2005.02289.X  0.624
2005 Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 60: 842-7. PMID 16085729 DOI: 10.1136/Thx.2005.043943  0.784
2005 Skorge TD, Eagan TML, Eide GE, Gulsvik A, Bakke PS. Indoor exposures and respiratory symptoms in a Norwegian community sample. Thorax. 60: 937-942. PMID 16055627 DOI: 10.1136/Thx.2004.025973  0.676
2005 Skorge TD, Eagan TM, Eide GE, Gulsvik A, Bakke PS. The adult incidence of asthma and respiratory symptoms by passive smoking in uterus or in childhood. American Journal of Respiratory and Critical Care Medicine. 172: 61-6. PMID 15805186 DOI: 10.1164/RCCM.200409-1158OC  0.673
2005 Lehmann S, Grebstad J, Fondenes O, Andreassen AH, Bakke P, Gulsvik A. [Treatment of obstructive sleep apnea]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 125: 199. PMID 15665900  0.537
2004 Lehmann S, Vollset SE, Nygaard HA, Gulsvik A. Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly. Respiratory Medicine. 98: 1071-9. PMID 15526807 DOI: 10.1016/J.Rmed.2004.03.019  0.36
2004 Eagan TM, Gulsvik A, Eide GE, Bakke PS. The effect of educational level on the incidence of asthma and respiratory symptoms. Respiratory Medicine. 98: 730-6. PMID 15303637 DOI: 10.1016/J.Rmed.2004.02.008  0.648
2004 Gunnbjörnsdóttir MI, Omenaas E, Gíslason T, Norrman E, Olin AC, Jõgi R, Jensen EJ, Lindberg E, Björnsson E, Franklin K, Janson C, Gulsvik A, Laerum B, Svanes C, Torén K, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. European Respiratory Journal. 24: 116-121. PMID 15293613 DOI: 10.1183/09031936.04.00042603  0.618
2004 Laerum BN, Svanes C, Gulsvik A, Iversen M, Thorarinsdottir HR, Gislason T, Jogi R, Norrman E, Gunnbjörnsdottir M, Wentzel-Larsen T, Janson C, Omenaas E. Is birth weight related to lung function and asthma symptoms in Nordic-Baltic adults? Respiratory Medicine. 98: 611-618. PMID 15250226 DOI: 10.1016/J.Rmed.2004.01.003  0.649
2004 Borg S, Ericsson A, Wedzicha J, Gulsvik A, Lundbäck B, Donaldson GC, Sullivan SD. A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 7: 153-67. PMID 15164805 DOI: 10.1111/J.1524-4733.2004.72318.X  0.376
2004 Eagan TML, Gulsvik A, Eide GE, Bakke PS. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study European Respiratory Journal. 23: 589-594. PMID 15083759 DOI: 10.1183/09031936.04.00041204  0.669
2004 Welle I, Eide GE, Gulsvik A, Bakke PS. Pulmonary gas exchange and educational level: a community study European Respiratory Journal. 23: 583-588. PMID 15083758 DOI: 10.1183/09031936.04.00106704  0.656
2004 Svanes C, Omenaas E, Jarvis D, Chinn S, Gulsvik A, Burney P. Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey Thorax. 59: 295-302. PMID 15047948 DOI: 10.1136/Thx.2003.009746  0.645
2004 Brogger J, Eagan T, Eide GE, Bakke P, Gulsvik A. Bias in retrospective studies of trends in asthma incidence. The European Respiratory Journal. 23: 281-6. PMID 14979504 DOI: 10.1183/09031936.03.00041103  0.791
2003 Svanes C, Heinrich J, Jarvis D, Chinn S, Omenaas E, Gulsvik A, Künzli N, Burney P. Pet-keeping in childhood and adult asthma and hay fever: European community respiratory health survey. The Journal of Allergy and Clinical Immunology. 112: 289-300. PMID 12897734 DOI: 10.1067/Mai.2003.1596  0.609
2003 Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking European Respiratory Journal. 21: 1017-1023. PMID 12797498 DOI: 10.1183/09031936.03.00053202  0.389
2003 Lundbäck B, Gulsvik A, Albers M, Bakke P, Rönmark E, van den Boom G, Brøgger J, Larsson LG, Welle I, van Weel C, Omenaas E. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. The European Respiratory Journal. Supplement. 40: 3s-9s. PMID 12762567 DOI: 10.1183/09031936.03.00403103  0.825
2003 Plessen CV, Grinde Ø, Gulsvik A. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respiratory Medicine. 97: 428-435. PMID 12693805 DOI: 10.1053/Rmed.2002.1466  0.342
2003 Fjellanger R, Brøgger JC, Eagan T, Gulsvik A. [Mortality after hospitalization for obstructive lung disease]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 123: 775-8. PMID 12693112  0.776
2003 Brogger J, Bakke P, Eide GE, Johansen B, Andersen A, Gulsvik A. Long-term changes in adult asthma prevalence. The European Respiratory Journal. 21: 468-72. PMID 12662003 DOI: 10.1183/09031936.03.00056103  0.794
2003 Brøgger J, Bakke P, Eide GE, Gulsvik A. Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. American Journal of Epidemiology. 157: 558-66. PMID 12631547 DOI: 10.1093/Aje/Kwg003  0.798
2003 Omenaas E, Fluge O, Buist AS, Vollmer WM, Gulsvik A. Dietary vitamin C intake is inversely related to cough and wheeze in young smokers. Respiratory Medicine. 97: 134-42. PMID 12587963 DOI: 10.1053/Rmed.2003.1439  0.632
2003 Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (London, England). 361: 449-56. PMID 12583942 DOI: 10.1016/S0140-6736(03)12459-2  0.403
2002 Jentoft HF, Omenaas E, Eide GE, Gulsvik A. Tuberculin reactivity: prevalence and predictors in BCG-vaccinated young Norwegian adults Respiratory Medicine. 96: 1033-1039. PMID 12477220 DOI: 10.1053/Rmed.2002.1386  0.6
2002 Svanes C, Jarvis D, Chinn S, Omenaas E, Gulsvik A, Burney P. Early exposure to children in family and day care as related to adult asthma and hay fever: results from the European Community Respiratory Health Survey. Thorax. 57: 945-950. PMID 12403876 DOI: 10.1136/Thorax.57.11.945  0.635
2002 Eagan TM, Eide GE, Gulsvik A, Bakke PS. Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. Journal of Clinical Epidemiology. 55: 775-81. PMID 12384191 DOI: 10.1016/S0895-4356(02)00431-6  0.667
2002 Eagan TM, Gulsvik A, Eide GE, Bakke PS. Occupational airborne exposure and the incidence of respiratory symptoms and asthma. American Journal of Respiratory and Critical Care Medicine. 166: 933-8. PMID 12359649 DOI: 10.1164/Rccm.200203-238Oc  0.676
2002 Eagan TML, Bakke PS, Eide GE, Gulsvik A. Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study European Respiratory Journal. 19: 599-605. PMID 11998986 DOI: 10.1183/09031936.02.00247302  0.667
2002 Jentoft HF, Omenaas E, Eide GE, Gulsvik A. Absence of relationship between tuberculin reactivity and asthmatic symptoms, level of FEV1 and bronchial hyperresponsiveness in BCG vaccinated young adults. Allergy. 57: 336-340. PMID 11906365 DOI: 10.1034/J.1398-9995.2002.1S3342.X  0.652
2002 Brøgger J, Bakke P, Eide GE, Gulsvik A. Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. American Journal of Epidemiology. 155: 572-6. PMID 11882531 DOI: 10.1093/Aje/155.6.572  0.797
2001 Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Forced spirometry reference values for Norwegian adults: The bronchial obstruction in nord-trøndelag study European Respiratory Journal. 18: 770-779. PMID 11757626 DOI: 10.1183/09031936.01.00255301  0.365
2001 Gulsvik A, Tosteson T, Bakke P, Humerfelt S, Weiss ST, Speizer FE. Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clinical Physiology (Oxford, England). 21: 648-60. PMID 11722472 DOI: 10.1046/J.1365-2281.2001.00377.X  0.764
2001 Gulsvik A, Beckett LA, Bakke P, Humerfelt S, Omenaas E, Speizer FE. Standardized submaximal exercise testing in never smokers: A normative study Clinical Physiology. 21: 629-636. PMID 11576165 DOI: 10.1046/J.1365-2281.2001.00363.X  0.778
2001 Bakke PS, Hanoa R, Gulsvik A. Relation of Occupational Exposure to Respiratory Symptoms and Asthma in a General Population Sample: Self-reported versus Interview-based Exposure Data American Journal of Epidemiology. 154: 477-483. PMID 11532790 DOI: 10.1093/Aje/154.5.477  0.647
2001 Welle I, Bakke PS, Eide GE, Fagerhol MK, Omenaas E, Gulsvik A. Increased circulating levels of α1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs European Respiratory Journal. 17: 1105-1111. PMID 11491151 DOI: 10.1183/09031936.01.00067501  0.74
2001 Jentoft HF, Omenaas E, Eide GE, Gulsvik A. Comparing the adrenaline-Pirquet test with international PPD tuberculin tests Respiratory Medicine. 95: 205-211. PMID 11266238 DOI: 10.1053/Rmed.2000.1023  0.559
2001 Brøgger J, Eide GE, Gulsvik A. Fev6 As A Surrogate For Fvc: Authors Should Have Included Roc-Curve Analyses American Journal of Respiratory and Critical Care Medicine. 163: 1759-1759. DOI: 10.1164/Ajrccm.163.7.16372F  0.757
2000 Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men the Nord-Trondelag health study (HUNT) Journal of Epidemiology and Community Health. 54: 917-922. PMID 11076988 DOI: 10.1136/Jech.54.12.917  0.359
2000 Gallefoss F, Bakke Ps, Wang IJh, Gilja Me, Gulsvik A. Smoking status, disease duration, and educational level in females, are related to asthma school participation. European Respiratory Journal. 15: 1022-1025. PMID 10885419 DOI: 10.1034/J.1399-3003.2000.01508.X  0.648
2000 Omenaas E, Jentoft HF, Vollmer WM, Buist AS, Gulsvik A. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax. 55: 454-8. PMID 10817791 DOI: 10.1136/Thorax.55.6.454  0.588
1999 Welle I, Eide GE, Bakke PS, Gulsvik A. The single-breath transfer factor for carbon monoxide and respiratory symptoms in a Norwegian community sample. European Respiratory Journal. 14: 1320-1325. PMID 10624761 DOI: 10.1183/09031936.99.14613209  0.682
1999 Aamodt AH, Bakke P, Gulsvik A. Reproducibility of indoor environment characteristics obtained in a walk through questionnaire. A pilot study. Indoor Air. 9: 26-32. PMID 10195273 DOI: 10.1111/J.1600-0668.1999.T01-3-00005.X  0.597
1998 Svanes C, Omenaas E, Eide GE, Fluge Ø, Gulsvik A. Hospitalization for lung disease in early childhood and asthma symptoms in young adulthood Respiratory Medicine. 92: 1003-1009. PMID 9893766 DOI: 10.1016/S0954-6111(98)90345-6  0.677
1998 Svanes C, Omenaas E, Heuch J, Irgens L, Gulsvik A. Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway European Respiratory Journal. 12: 1366-1370. PMID 9877492 DOI: 10.1183/09031936.98.12061366  0.645
1998 Welle I, Eide GE, Bakke P, Gulsvik A. Applicability of the single-breath carbon monoxide diffusing capacity in a Norwegian Community Study. American Journal of Respiratory and Critical Care Medicine. 158: 1745-50. PMID 9847262 DOI: 10.1164/Ajrccm.158.6.9712123  0.633
1998 Humerfelt S, Eide GE, Gulsvik A. Association of years of occupational quartz exposure with spirometric airflow limitation in Norwegian men aged 30-46 years. Thorax. 53: 649-55. PMID 9828850 DOI: 10.1136/Thx.53.8.649  0.66
1998 Fluge O, Omenaas E, Eide G, Gulsvik A. Fish consumption and respiratory symptoms among young adults in a Norwegian community. European Respiratory Journal. 12: 336-340. PMID 9727781 DOI: 10.1183/09031936.98.12020336  0.639
1998 Humerfelt S, Eide GE, Kvåle G, Gulsvik A. Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) variability in asymptomatic never-smoking men. Clinical Physiology (Oxford, England). 18: 387-96. PMID 9715766 DOI: 10.1046/J.1365-2281.1998.00115.X  0.68
1998 Nystad W, Magnus P, Gulsvik A. Increasing risk of asthma without other atopic diseases in school children: A repeated cross-sectional study after 13 years European Journal of Epidemiology. 14: 247-252. PMID 9663517 DOI: 10.1023/A:1007453322547  0.34
1998 Humerfelt S, Eide GE, Kvåle G, Aarø LE, Gulsvik A. Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure. The European Respiratory Journal. 11: 284-90. PMID 9551726 DOI: 10.1183/09031936.98.11020284  0.669
1997 Burney P, Chinn S, Luczynska C, Jarvis D, Vermeire P, Bousquet J, Nowak D, Prichard J, De Marco R, Rijcken B, Anto J, Alves J, Boman G, Nielsen N, Paoletti P, ... ... Gulsvik A, et al. Genes for asthma? An analysis of the European Community Respiratory Health Survey American Journal of Respiratory and Critical Care Medicine. 156: 1773-1780. PMID 9412554 DOI: 10.1164/Ajrccm.156.6.9611068  0.63
1997 Nystad W, Magnus P, Gulsvik A, Skarpaas IJK, Carlsen K-. Changing prevalence of asthma in school children: evidence for diagnostic changes in asthma in two surveys 13 yrs apart. European Respiratory Journal. 10: 1046-1051. PMID 9163645 DOI: 10.1183/09031936.97.10051046  0.366
1996 Eide GE, Omenaas E, Gulsvik A. The Semi-Proportional Hazards Model Revisited: Practical Reparametrizations Statistics in Medicine. 15: 1771-1777. PMID 8870159 DOI: 10.1002/(Sici)1097-0258(19960830)15:16<1771::Aid-Sim327>3.0.Co;2-X  0.611
1996 Omenaas E, Bakke P, Eide GE, Elsayed S, Gulsvik A. Serum house dust mite antibodies: predictor of increased bronchial responsiveness in adults of a community. The European Respiratory Journal. 9: 919-25. PMID 8793452 DOI: 10.1183/09031936.96.09050919  0.736
1996 Omenaas E, Bakke P, Eide GE, Haukenes G, Gulsvik A. Serum respiratory virus antibodies: predictor of reduced one-second forced expiratory volume (FEV1) in Norwegian adults. International Journal of Epidemiology. 25: 134-41. PMID 8666481 DOI: 10.1093/Ije/25.1.134  0.725
1995 Omenaas E, Bakke P, Haukenes G, Hanoa R, Gulsvik A. Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. International Journal of Epidemiology. 24: 223-31. PMID 7797347 DOI: 10.1093/Ije/24.1.223  0.729
1995 Bakke PS, Hanoa R, Gulsvik A. Educational Level and Obstructive Lung Disease Given Smoking Habits and Occupational Airborne Exposure: A Norwegian Community Study American Journal of Epidemiology. 141: 1080-1088. PMID 7771443 DOI: 10.1093/Oxfordjournals.Aje.A117373  0.678
1995 Humerfelt S, Eide GE, Kvåle G, Gulsvik A. Predictors of spirometric test failure: a comparison of the 1983 and 1993 acceptability criteria from the European Community for Coal and Steel. Occupational and Environmental Medicine. 52: 547-53. PMID 7663642 DOI: 10.1136/Oem.52.8.547  0.595
1995 Omenaas E, Bakke P, Eide GE, Elsayed S, Gulsvik A. Total serum IgE and FEV1 by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. 25: 682-9. PMID 7584678 DOI: 10.1111/J.1365-2222.1995.Tb00004.X  0.766
1995 Omenaas E, Bakke P, Eide GE, Elsayed S, Gulsvik A. Serum house-dust-mite antibodies and reduced FEV1 in adults of a Norwegian community. American Journal of Respiratory and Critical Care Medicine. 152: 1158-63. PMID 7551364 DOI: 10.1164/Ajrccm.152.4.7551364  0.761
1994 Omenaas E, Bakke P, Elsayed S, Hanoa R, Gulsvik A. Total and specific serum IgE levels in adults: relationship to sex, age and environmental factors. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. 24: 530-9. PMID 7922774 DOI: 10.1111/J.1365-2222.1994.Tb00950.X  0.754
1994 Boe J, Bakke P, Rødølen T, Skovlund E, Gulsvik A. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. The European Respiratory Journal. 7: 2179-84. PMID 7713201 DOI: 10.1183/09031936.94.07122179  0.602
1993 Thorsen E, Segadal K, Kambestad BK, Gulsvik A. Pulmonary function one and four years after a deep saturation dive. Scandinavian Journal of Work, Environment & Health. 19: 115-120. PMID 8316778 DOI: 10.5271/Sjweh.1498  0.332
1992 Bakke P, Baste V, Hanoa R, Gulsvik A. Occupational airborne exposure of the general population of a Norwegian county. Scandinavian Journal of Work, Environment & Health. 18: 44-51. PMID 1553512 DOI: 10.5271/SJWEH.1609  0.592
1992 Gulsvik A, Bakke P, Humerfelt S, Omenaas E, Tosteson T, Weiss ST, Speizer FE. Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. Thorax. 47: 167-73. PMID 1519193 DOI: 10.1136/Thx.47.3.167  0.781
1991 Bakke PS, Baste V, Gulsvik A. Bronchial responsiveness in a Norwegian community. The American Review of Respiratory Disease. 143: 317-322. PMID 1990946 DOI: 10.1164/Ajrccm/143.2.317  0.644
1991 Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax. 46: 863-870. PMID 1792631 DOI: 10.1136/Thx.46.12.863  0.699
1990 Thorsen E, Segadal K, Kambestad B, Gulsvik A. Divers' lung function: small airways disease? Occupational and Environmental Medicine. 47: 519-523. PMID 2393630 DOI: 10.1136/Oem.47.8.519  0.381
1990 Bakke P, Gulsvik A, Eide GE, Hanoa R. Smoking habits and lifetime occupational exposure to gases or dusts, including asbestos and quartz, in a Norwegian community. Scandinavian Journal of Work, Environment & Health. 16: 195-202. PMID 2382122 DOI: 10.5271/Sjweh.1794  0.632
1990 Thorsen E, Segadal K, Myrseth E, Påsche A, Gulsvik A. Pulmonary mechanical function and diffusion capacity after deep saturation dives. Occupational and Environmental Medicine. 47: 242-247. PMID 2337532 DOI: 10.1136/Oem.47.4.242  0.333
1990 Bakke P, Gulsvik A, Lilleng P, Overå O, Hanoa R, Eide GE. Postal survey on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-response. Journal of Epidemiology and Community Health. 44: 316-20. PMID 2277255 DOI: 10.1136/Jech.44.4.316  0.629
1990 Bakke P, Gulsvik A, Eide GE. Hay fever, eczema and urticaria in southwest Norway. Lifetime prevalences and association with sex, age, smoking habits, occupational airborne exposures and respiratory symptoms. Allergy. 45: 515-22. PMID 2252162 DOI: 10.1111/J.1398-9995.1990.Tb00527.X  0.669
1990 Akslen LA, Myking AO, Mørkve O, Gulsvik A, Raithel HJ, Schaller KH. Increased Content of Chromium and Nickel in Lung Tissues from Patients with Bronchial Carcinoma Pathology Research and Practice. 186: 717-722. PMID 2084637 DOI: 10.1016/S0344-0338(11)80261-X  0.332
1989 Lønning PE, Bakke P, Thorsen T, Olsen B, Gulsvik A. Plasma levels of estradiol, estrone, estrone sulfate and sex hormone binding globulin in patients receiving rifampicin. Journal of Steroid Biochemistry. 33: 631-5. PMID 2811375 DOI: 10.1016/0022-4731(89)90052-6  0.536
1988 Vik-Mo H, Gulsvik A, Folling M. Cardiopulmonary effects of enprofylline: a xanthine with weak adenosine receptor antagonism in patients with severe chronic lung disease Chest. 94: 354-359. PMID 3396415 DOI: 10.1378/Chest.94.2.354  0.346
1986 Gulsvik A, Kjelsberg F, Bergmann A, Frøland SS, Rootwelt K, Vale JR. High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study. Respiration; International Review of Thoracic Diseases. 50: 252-7. PMID 3823635 DOI: 10.1159/000194935  0.575
1986 Wisborg T, Bakke P, Gulsvik A. New syringes for arterial blood sampling. Anaesthesia. 41: 866-7. PMID 3752471 DOI: 10.1111/J.1365-2044.1986.Tb13135.X  0.576
1986 McCullough PC, Cole RP, Baumann UA, Haerdi E, Keller R, Wengrower D, Tzfoni EE, Drenger B, Leitersdorf E, Traunecker W, Muacevic G, Gulsvik A, Kjelsberg F, Bergmann A, Frøland SS, et al. Subject Index, Vol. 50, 1986 Respiration. 50: 305-306. DOI: 10.1159/000194944  0.57
1986 McCullough PC, Cole RP, Baumann UA, Haerdi E, Keller R, Wengrower D, Tzfoni EE, Drenger B, Leitersdorf E, Traunecker W, Muacevic G, Gulsvik A, Kjelsberg F, Bergmann A, Frøland SS, et al. Contents, Vol. 50, 1986 Respiration. 50. DOI: 10.1159/000194932  0.538
1981 Vale JR, Gulsvik A, Kongerud J. Random error with the FEV1 = case for absolute values. Lancet (London, England). 2: 313. PMID 6114360 DOI: 10.1016/S0140-6736(81)90569-9  0.553
Show low-probability matches.